Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo.
about
Scavenger receptor SR-BI in macrophage lipid metabolismAntagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosisWhat does procollagen C-endopeptidase enhancer protein 2 have to do with HDL-cholesteryl ester uptake? Or how I learned to stop worrying and love reverse cholesterol transport?A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretionBile acid signaling in metabolic disease and drug therapyEnhanced atheroprotection and lesion remodelling by targeting the foam cell and increasing plasma cholesterol acceptorsEffects of berberine on expression of LOX-1 and SR-BI in human macrophage-derived foam cells induced by ox-LDLThe liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in miceDifferent cellular traffic of LDL-cholesterol and acetylated LDL-cholesterol leads to distinct reverse cholesterol transport pathwaysMacrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivoInflammation and skin cholesterol in LDLr-/-, apoA-I-/- mice: link between cholesterol homeostasis and self-tolerance?Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart diseaseMendelian randomization in cardiometabolic disease: challenges in evaluating causality.Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice.Effect of Centella asiatica on oxidative stress and lipid metabolism in hyperlipidemic animal models.Human SR-BII mediates SAA uptake and contributes to SAA pro-inflammatory signaling in vitro and in vivoScavenger receptor BI facilitates hepatic very low density lipoprotein production in mice.Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia.alpha(1)-fetoprotein transcription factor (FTF)/liver receptor homolog-1 (LRH-1) is an essential lipogenic regulatorPathways by which reconstituted high-density lipoprotein mobilizes free cholesterol from whole body and from macrophagesRole of the adaptor protein PDZK1 in controlling the HDL receptor SR-BIOxidized LDL: diversity, patterns of recognition, and pathophysiology.New developments in selective cholesteryl ester uptake.Regulation of high-density lipoprotein on hematopoietic stem/progenitor cells in atherosclerosis requires scavenger receptor type BI expression.Adipocyte modulation of high-density lipoprotein cholesterol.Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitorsEffect of recombinant human lecithin cholesterol acyltransferase infusion on lipoprotein metabolism in mice.Scavenger receptor class B type I: a multifunctional receptor.SR-BI/CD36 chimeric receptors define extracellular subdomains of SR-BI critical for cholesterol transport.The atherogenic Scarb1 null mouse model shows a high bone mass phenotypeFunctional characterization of newly-discovered mutations in human SR-BIScavenger receptor class B, type I (Scarb1) deficiency promotes osteoblastogenesis but stunts terminal osteocyte differentiation.Omega 3 fatty acids promote macrophage reverse cholesterol transport in hamster fed high fat diet.Negatively cooperative binding of high-density lipoprotein to the HDL receptor SR-BICholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis.SR-BI in bone marrow derived cells protects mice from diet induced coronary artery atherosclerosis and myocardial infarction.Melanocortin signaling in the CNS directly regulates circulating cholesterol.Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissuesRosiglitazone attenuates atherosclerosis and increases high-density lipoprotein function in atherosclerotic rabbits.
P2860
Q24299462-7394F6D5-A555-430B-95DA-ED0E5DE1E30BQ24634165-553DD4F4-9495-4CC4-8941-8466DB940480Q26821862-301FED1A-07BE-4666-B22F-27F822927857Q26865600-A29E103E-18A4-4AD0-8330-25B7E7057DF4Q28244875-1EC98B81-6E87-4EC0-BB76-4C4091B19619Q28268889-A0682D90-24F2-4AD7-ABA6-BEC7553A65DDQ28297920-4D17DA77-65D6-43BE-A3F5-CFDBB984546CQ28472536-5F32D692-58F5-490E-BE50-1C7A4C1748F2Q28505513-EF6F389E-B4E4-4140-BCDC-ADE3C2D3AA6DQ28508467-BB97355E-4D4F-4180-9150-7046DAA361D3Q28588533-33049D42-961D-49F8-8160-66CCFE4EF0E4Q29147547-666FFF75-EC23-4389-83A4-C0DB7309E538Q30234302-21452FCA-A902-4A43-9D67-0C0A5F80F214Q30942732-BE310B43-691C-49CE-858A-9A486DC25B90Q33562954-D9E9142F-70C1-4F5C-A0B9-FED5CCB00C67Q33579601-8D053FE4-DF25-4BB2-BB5F-86E574536388Q33634141-9C660889-F584-40D6-9964-62C7F3D48E87Q33661459-BA1CEDB2-D39D-43AB-9109-BC49C384B825Q33678751-376C3021-FA95-4B44-A47A-8D069E4CCC59Q33743839-0C032E89-356E-45AD-8403-24DF9BFBF220Q33767978-6A2120D5-D533-4393-84B3-2601975FE012Q33879138-2A51C2DC-2F45-4EB2-83FF-C48CE761FD09Q33894679-66BE9E4C-2CDB-45A5-866F-BA30EB0543B1Q34076242-43E99C36-EF5B-4FCE-8B08-5F52F0F7EA94Q34077609-69FF06E3-1651-446F-B683-A9C6ECA24DF4Q34155049-7E656244-8003-49B2-B62F-C8D8B98E1190Q34178582-AE0D80ED-D1A0-4819-885C-10A237B691B3Q34214772-BB7CAA45-2FFA-4CF2-9C64-45241EC49981Q34246570-0A46687C-9F46-4DF3-B1D3-D3212B2CBCBFQ34300349-90FD43B1-7831-4FAC-929B-F35349C3E048Q34386283-7F74C4CF-F7FA-4F30-BE5B-2DB4F893BAD2Q34429737-D4C69D13-C95A-49B7-AB27-AA1947EE1C47Q34622857-747BB72A-EFA7-4340-8B0A-F224AAB95603Q34684069-B5D6936E-27D8-4185-BF78-BAF9918936A9Q34726050-20B819A9-16C6-459F-BE7B-C6A7E604F015Q34948139-3E3F2A91-2B84-4064-B5CD-1049A806C149Q34965254-60878707-F077-42E1-A6D5-3F96B241BB09Q34999515-9D8645EE-20AF-4806-AE29-ADFF12E50A04Q35017869-37EB34CF-E34E-4C9B-B265-18F81F24200EQ35040072-1024E36E-0A49-4E60-92C1-B13B8D252CBB
P2860
Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Hepatic expression of scavenge ...... cholesterol transport in vivo.
@ast
Hepatic expression of scavenge ...... cholesterol transport in vivo.
@en
Hepatic expression of scavenger receptor class B type I
@nl
type
label
Hepatic expression of scavenge ...... cholesterol transport in vivo.
@ast
Hepatic expression of scavenge ...... cholesterol transport in vivo.
@en
Hepatic expression of scavenger receptor class B type I
@nl
prefLabel
Hepatic expression of scavenge ...... cholesterol transport in vivo.
@ast
Hepatic expression of scavenge ...... cholesterol transport in vivo.
@en
Hepatic expression of scavenger receptor class B type I
@nl
P2093
P2860
P356
P1476
Hepatic expression of scavenge ...... cholesterol transport in vivo.
@en
P2093
Daniel J Rader
George H Rothblat
Jaqueline R Da Silva
Jeffrey T Billheimer
Muredach Reilly
YuZhen Zhang
P2860
P304
P356
10.1172/JCI25327
P407
P577
2005-10-01T00:00:00Z